CClinicalTrials.gg
CompletedNCT01590524Updated Oct 8, 2014

Feasibility Study on the Effect of Complementary Methods as Supportive Interventions for Parents of Children With Cancer

An interventional study of Guided Imagery and Progressive Muscle Relaxation in Anxiety, Stress and Mood, sponsored by Cyprus University of Technology. Completed at 1 site in Cyprus. Per ClinicalTrials.gov, last updated 2014-10-08.

Sponsored by Cyprus University of Technology · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Sex
All
01

Study summary

The purpose of this study is to determine whether Guided Imagery and Progressive Muscle relaxation are effective as stress reducing techniques in parents of hospitalized children with cancer.

Read the detailed description

Having a children with cancer can be a source of stress for parents during hospitalization. The stress experienced by the parents can negatively influence their functionality, daily activities, psychological state and also their physical condition. The studies in the literature have mainly focused on the child rather than the parent, and studies specifically for guided imagery are scarce. Since the parents are often neglected by the healthcare professionals during the stress evoking period of hospitalization, this study will test the effectiveness of complementary methods in improving the psychological state of the parents.

02

Conditions studied

  • Anxiety
  • Stress
  • Mood
  • Coping

Browse trials for

Keywords

  • Parent
  • childhood cancer
  • Complementary and Alternative
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 52 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Cyprus University of Technology is the lead sponsor of 27 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • willingness to participate
  • having a child with childhood cancer been hospitalized for 4 weeks
  • have a child (0-18) of age with childhood cancer
  • able to speak and write Greek fluently
  • no previous experience with CAM techniques

Exclusion criteria

Exclusion Criteria:

  • receiving drug therapy for stress
  • using another CAM technique during the study

    • parents of children receiving palliative care
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
52 participants (actual)

Study arms

  • Experimental
    CAM group

    Subjects receiving the interventions and standard psychological care

    Behavioral: Guided Imagery and Progressive Muscle Relaxation

  • No intervention
    No-CAM group

    Parents receiving only standard psychological care

Interventions

  • BehavioralGuided Imagery and Progressive Muscle Relaxation

    Daily implementation of the guided imagery and progressive muscle relaxation techniques additionally to weekly supervised sessions.

06

What researchers measure

Primary outcomes

  1. Changes in the number of Participants with anxiety

    Participants response to the complementary and alternative intervention will be measured through their scores on the Hamilton Anxiety Scale

    Time frame: 1 week, 2 week, 3 week , 4 week

Secondary outcomes

  1. Changes in the number of Participants with mood changes

    Participants response to the complementary and alternative interventions will be measured through their scores on the POMS scale

    Time frame: 1 week, 2 week, 3 week , 4 week

  2. stress level with Biodots

    Time frame: 1 week, 2 week, 3 week, 4 week

07

Study locations

1 site
  • Archbishob Makarios Hospital
    Nicosia, 2012, Cyprus
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 8, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01590524
Lead sponsor
Cyprus University of Technology
Responsible party
Dr. Andreas Charalambous (Lecturer-Researcher, Cyprus University of Technology) — Principal investigator
First posted
May 3, 2012
Start date
Apr 2012
Primary completion
Sep 2014
Completion
Oct 2014
Last update
Oct 8, 2014

Study contacts

Andreas Charalambous, PhD
principal investigator · Cyprus University of Technology

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion